Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will characterize the safety, tolerability, biological activity, and
pharmacokinetics of LBH589 in Japanese patients with advanced solid tumors whose disease has
progressed despite standard therapies, or for whom no standard therapy exists.